RTW Biotech Opportunities (LON:RTW – Get Free Report) reached a new 52-week high during trading on Wednesday . The stock traded as high as GBX 2.49 and last traded at GBX 2.48, with a volume of 214529 shares traded. The stock had previously closed at GBX 2.44.
RTW Biotech Opportunities Stock Performance
The business has a 50 day moving average price of GBX 2.29 and a 200 day moving average price of GBX 2.17. The company has a quick ratio of 0.81, a current ratio of 0.15 and a debt-to-equity ratio of 20.05. The stock has a market cap of £7.88 million, a P/E ratio of 0.04 and a beta of 1.23.
RTW Biotech Opportunities Company Profile
RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives. RTW Bio is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
Featured Stories
- Five stocks we like better than RTW Biotech Opportunities
- Plugging In: How Kinder Morgan Powers Up Profits
- Freeport McMoRan Post-Earnings: Why Good Enough May Finally Be Good Enough
- TSMC’s Price Hikes Could Show Which AI Chip Stocks Have Real Pricing Power
- Tesla Just Delivered Record Sales—So Why Did the Stock Sell Off?
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
